top of page

Artificial Intelligence in Oncology 2023:
A Comprehensive Analysis

From the realms of artificial intelligence to the horizons of medical innovation — explore the factors influencing the AI-driven advancements in oncology.

This analytical report provides the most extensive perspective on the current status of AI in Oncology up to this point, spotlighting key stakeholders, trends, and technologies.

Whether you're a professional, investor, or enthusiast, this serves as your guiding tool to navigate the AI-infused landscape of oncology advancements. The future lies in AI — empower yourself to welcome it.

Dive deep into:

​

  • Benchmarking performances of the major AI players in oncology

​​

  • Thoughtfully crafted educative mindmaps and infographics

​​

  • Comprehensive understanding of the exponential surge in investments: leadership of AI companies based on funding levels, with a focus on those with total funding exceeding $15M.

Full Report
70 Pages
Screenshot 2023-08-15 at 13.09_edited.jpg

The transformation of oncology R&D has reached unprecedented depths. Our latest report, "AI in Oncology 2023," illuminates the crucial role AI assumes in the landscape of oncology advancements. Experience a detailed examination of 140 AI BioTech companies, 20 distinguished R&D Hubs, and the financial activities of 475investors fervently propelling progress in the artificial intelligence domain of pharmaceuticals and healthcare, with a specific focus on oncology.

Report Highlights
 

  • Exploring AI in Oncology Advancements: Laying the groundwork for the road ahead.​​

​

  • Prominent Achievements & Cutting-Edge Research in Oncology: Grasp pivotal breakthroughs and the latest explorations in research.

​​

  • Frontline AI Pioneers & Key Oncology Collaborations: An extensive overview of the trailblazers in the AI-Oncology landscape.

​​

  • Geographic Analysis: Uncover the birthplaces and nurturing grounds of innovative developments.

​​

  • Market Dynamics & Investment Landscape: From influential investors to the financial strategies adopted by leading entities.

​​​

  • Computational Brilliance in Oncology: Delve deep into the methodologies steering the forefront AI leaders.​​

​​​

  • Oncology R&D Applications & Industry Progression: Embark on a journey from 2021 to 2023, tracing the evolution.

​

  • Insights & Projections: Evaluating the surging interest and investments directed towards harnessing AI's potential in expediting oncology advancements.
     

Please fill out the form below
to access the full Report
bottom of page